Literature DB >> 24972003

Autoantibodies in pre-clinical autoimmune disease.

Zhi-De Hu1, An-Mei Deng2.   

Abstract

The presence of autoantibodies is characteristic of autoimmune diseases. It is widely accepted that autoantibodies provide crucial diagnostic and prognostic information for autoimmune diseases. Indeed, numerous studies have demonstrated that the appearance of autoantibodies precedes the clinical onset of autoimmune diseases. We performed a literature review regarding the appearance of autoantibodies that preceded the clinical onset of autoimmune diseases, including rheumatoid arthritis, systemic lupus erythematosus, Sjögren's syndrome, primary biliary cirrhosis, inflammatory bowel disease, and multiple sclerosis. Herein we review and comment on the major findings of these studies.
Copyright © 2014. Published by Elsevier B.V.

Entities:  

Keywords:  Autoantibodies; Autoimmune disease; Pre-clinical phase

Mesh:

Substances:

Year:  2014        PMID: 24972003     DOI: 10.1016/j.cca.2014.06.015

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  10 in total

1.  Hyperprolactinemia is associated with a high prevalence of serum autoantibodies, high levels of inflammatory cytokines and an abnormal distribution of peripheral B-cell subsets.

Authors:  Yaoyang Liu; Zhiguo Zhang; Qianmei Jin; Yang Liu; Zijian Kang; Yongbao Huo; Zhengwen He; Xu Feng; Jian Yin; Xin Wu; Huaizhou Wang; Huji Xu
Journal:  Endocrine       Date:  2019-03-18       Impact factor: 3.633

2.  Familial co-aggregation of attention-deficit/hyperactivity disorder and autoimmune diseases: a cohort study based on Swedish population-wide registers.

Authors:  Tor-Arne Hegvik; Qi Chen; Ralf Kuja-Halkola; Kari Klungsøyr; Agnieszka Butwicka; Paul Lichtenstein; Catarina Almqvist; Stephen V Faraone; Jan Haavik; Henrik Larsson
Journal:  Int J Epidemiol       Date:  2022-06-13       Impact factor: 9.685

3.  Prediction of Immune-Related Adverse Events Induced by Immune Checkpoint Inhibitors With a Panel of Autoantibodies: Protocol of a Multicenter, Prospective, Observational Cohort Study.

Authors:  Iñigo Les; Inés Pérez-Francisco; María Cabero; Cristina Sánchez; María Hidalgo; Lucía Teijeira; Virginia Arrazubi; Severina Domínguez; Pilar Anaut; Saioa Eguiluz; Iñaki Elejalde; Alberto Herrera; Mireia Martínez
Journal:  Front Pharmacol       Date:  2022-06-01       Impact factor: 5.988

4.  Comparison of the diagnostic potential of three anti-citrullinated protein antibodies as adjuncts to rheumatoid factor and CCP in a cohort of South African rheumatoid arthritis patients.

Authors:  Pieter W A Meyer; Mahmood T M Ally; Bridget Hodkinson; Ronald Anderson; Mohammed Tikly
Journal:  Rheumatol Int       Date:  2018-04-30       Impact factor: 2.631

5.  Current Techniques to Accurately Measure Anti-retinal Autoantibodies.

Authors:  Grazyna Adamus
Journal:  Expert Rev Ophthalmol       Date:  2020-03-12

6.  Foxp3⁺ Treg Cells Are Associated with Pathological Process of Autoimmune Hepatitis by Activating Methylation Modification in Autoimmune Hepatitis Patients.

Authors:  Jiang Chen; Wen Liu; Wenjing Zhu
Journal:  Med Sci Monit       Date:  2019-08-18

7.  Development of Systemic Autoimmune Diseases in Healthy Subjects Persistently Positive for Antiphospholipid Antibodies: Long-Term Follow-Up Study.

Authors:  Fulvia Ceccarelli; Francesco Natalucci; Giulio Olivieri; Carmelo Pirone; Licia Picciariello; Valeria Orefice; Simona Truglia; Francesca Romana Spinelli; Cristiano Alessandri; Antonio Chistolini; Fabrizio Conti
Journal:  Biomolecules       Date:  2022-08-07

8.  Relationships among Antibodies against Extractable Nuclear Antigens, Antinuclear Antibodies, and Autoimmune Diseases in a Brazilian Public Hospital.

Authors:  Fernanda Weyand Banhuk; Bruna Corrêa Pahim; Alex Sandro Jorge; Rafael Andrade Menolli
Journal:  Autoimmune Dis       Date:  2018-09-30

9.  Diagnostic utility of, and influence of tobacco usage and genetic predisposition on, immunoglobulin A, rheumatoid factor and anti-citrullinated peptide auto-antibodies in South African rheumatoid arthritis patients.

Authors:  Pieter Meyer; Mahmood Ally; Bridget Hodkinson; Ronald Anderson; Mohammed Tikly
Journal:  Afr Health Sci       Date:  2018-06       Impact factor: 0.927

10.  Serological abnormalities that predict progression to systemic autoimmune rheumatic diseases in antinuclear antibody-positive individuals.

Authors:  Carolina Muñoz-Grajales; Stephenie D Prokopec; Sindhu R Johnson; Zahi Touma; Zareen Ahmad; Dennisse Bonilla; Linda Hiraki; Arthur Bookman; Paul C Boutros; Andrzej Chruscinski; Joan Wither
Journal:  Rheumatology (Oxford)       Date:  2022-03-02       Impact factor: 7.046

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.